Assessment of a Test for the Screening and Diagnosis of Celiac Disease - PubMed (original) (raw)
Assessment of a Test for the Screening and Diagnosis of Celiac Disease
Brunetta Porcelli et al. J Clin Lab Anal. 2016 Jan.
Abstract
Background: Celiac disease (CD) is an immune-mediated intolerance to dietary gluten, affecting genetically predisposed individuals. ELISA-based serological tests help to decide if further duodenal biopsy is necessary, for this the diagnostic kits have to be accurate, specific, and sensible. In this study, we investigate the performance of an ELISA that uses the purified cross-linked complex of tissue transglutaminase and gliadin, referred as the "neoepitope" (AESKULISA® tTG New Generation), as antigen.
Methods: We evaluated 41 newly diagnosed celiac patients, 18 celiac patients on gluten-free diet, and 169 controls, comprising healthy subjects, patients affected by other autoimmune diseases, and patients affected by several non-autoimmune diseases.
Results and conclusion: The assay has an excellent performance. Due to its high level of diagnostic accuracy, this assay constitutes a new approach for the screening of celiac patients not only for the diagnosis of CD, but also for monitoring patients on gluten-free diet and their compliance. Moreover, cases of neoepitope-positive subjects who were tested negative with "classical" serological markers could have a predictive value for this pathology. This aspect will require further studies of elaboration.
Keywords: anti-cross-linked complex antibodies; antideamidated gliadin peptides antibodies; antitissue transglutaminase antibodies; celiac disease; neoepitope.
© 2014 Wiley Periodicals, Inc.
Similar articles
- Diagnostic accuracy of a new point-of-care screening assay for celiac disease.
Benkebil F, Combescure C, Anghel SI, Besson Duvanel C, Schäppi MG. Benkebil F, et al. World J Gastroenterol. 2013 Aug 21;19(31):5111-7. doi: 10.3748/wjg.v19.i31.5111. World J Gastroenterol. 2013. PMID: 23964145 Free PMC article. - Antitissue transglutaminase antibodies outside celiac disease.
Clemente MG, Musu MP, Frau F, Lucia C, De Virgiliis S. Clemente MG, et al. J Pediatr Gastroenterol Nutr. 2002 Jan;34(1):31-4. doi: 10.1097/00005176-200201000-00008. J Pediatr Gastroenterol Nutr. 2002. PMID: 11753161 - Sequential testing with different tissue transglutaminase antibodies, a new approach for diagnosis of celiac disease.
Venugopal G, Mechenro J, Makharia G, Singh A, Pugazhendhi S, Balamurugan R, Ramakrishna BS. Venugopal G, et al. Indian J Gastroenterol. 2017 Nov;36(6):481-486. doi: 10.1007/s12664-017-0803-z. Epub 2017 Dec 22. Indian J Gastroenterol. 2017. PMID: 29270909 - Diagnosis and classification of celiac disease and gluten sensitivity.
Tonutti E, Bizzaro N. Tonutti E, et al. Autoimmun Rev. 2014 Apr-May;13(4-5):472-6. doi: 10.1016/j.autrev.2014.01.043. Epub 2014 Jan 15. Autoimmun Rev. 2014. PMID: 24440147 Review. - Celiac disease in children.
Benelli E, Zin A, Martelossi S. Benelli E, et al. Minerva Pediatr. 2019 Feb;71(1):39-46. doi: 10.23736/S0026-4946.18.05366-5. Epub 2018 Jul 18. Minerva Pediatr. 2019. PMID: 30021413 Review.
Cited by
- Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.
Agardh D, Matthias T, Wusterhausen P, Neidhöfer S, Heller A, Lerner A. Agardh D, et al. Clin Exp Immunol. 2020 Mar;199(3):294-302. doi: 10.1111/cei.13394. Epub 2019 Nov 11. Clin Exp Immunol. 2020. PMID: 31663117 Free PMC article. - Predictors of slow responsiveness and partial mucosal recovery in adult patients with celiac disease.
Nemteanu R, Danciu M, Clim A, Girleanu I, Ciortescu I, Gheorghe L, Trifan A, Plesa A. Nemteanu R, et al. Gastroenterol Hepatol Bed Bench. 2023;16(2):194-202. doi: 10.22037/ghfbb.v16i2.2734. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37554747 Free PMC article. - Celiac disease in the East and the West: Bridging the gaps between the guidelines and their implementation in daily practice is mandatory.
Dhawan A, Agarwal A, Mulder CJ, Makharia GK. Dhawan A, et al. Indian J Gastroenterol. 2019 Jun;38(3):185-189. doi: 10.1007/s12664-019-00970-7. Indian J Gastroenterol. 2019. PMID: 31313236 Review. No abstract available. - Autoantibody testing by enzyme-linked immunosorbent assay-a case in which the solid phase decides on success and failure.
Deutschmann C, Roggenbuck D, Schierack P, Rödiger S. Deutschmann C, et al. Heliyon. 2020 Jan 18;6(1):e03270. doi: 10.1016/j.heliyon.2020.e03270. eCollection 2020 Jan. Heliyon. 2020. PMID: 31993528 Free PMC article. - Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies.
Warkad SD, Song KS, Pal D, Nimse SB. Warkad SD, et al. Sensors (Basel). 2019 Sep 30;19(19):4257. doi: 10.3390/s19194257. Sensors (Basel). 2019. PMID: 31575036 Free PMC article. Review.
References
- Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 2001;120:636–651. - PubMed
- Shan L, Molberg O, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002;297:2275–2279. - PubMed
- Fleckenstein B, Molberg O, Qiao SW, et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J Biol Chem 2002;277:34109–34116. - PubMed
- Fleckenstein B, Qiao SW, Larsen MR, Jung G, Roepstorff P, Sollid LM. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004;279:17607–17616. - PubMed
- Skovbjerg H, Koch C, Anthonsen D, Sjostrom H. Deamidation and cross‐linking of gliadin peptides by transglutaminase and the relation to celiac disease. Biochim Biophys Acta 2004;1690:220–230. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical